+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hormonal Contraceptives Market by Contraceptive Type, Hormonal Composition, Sales Channel, End User - Global Forecast to 2030- Product Image
Hormonal Contraceptives Market by Contraceptive Type, Hormonal Composition, Sales Channel, End User - Global Forecast to 2030- Product Image
Sale

Hormonal Contraceptives Market by Contraceptive Type, Hormonal Composition, Sales Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5206450
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Hormonal Contraceptives Market grew from USD 18.34 billion in 2024 to USD 19.64 billion in 2025. It is expected to continue growing at a CAGR of 6.79%, reaching USD 27.21 billion by 2030.

Charting the Course of Hormonal Contraceptive Innovation

The hormonal contraceptives landscape is undergoing a profound evolution, driven by scientific breakthroughs, shifting patient preferences, and dynamic regulatory environments. Innovations in delivery systems, from implants and injectable formulations to transdermal patches and vaginal rings, are expanding the range of options available to women worldwide. At the same time, the emergence of new hormonal compositions and the refinement of existing ones are enabling more personalized approaches to reproductive health.

As the industry enters this next chapter, stakeholders must navigate complex variables-technological advances, market fragmentation, and changing reimbursement frameworks-while maintaining focus on safety, efficacy, and accessibility. This executive summary synthesizes the critical factors shaping the market today, setting the stage for data-driven strategies that unlock value and foster sustainable growth.

Shifting Paradigms in Hormonal Birth Control Advancements

Recent years have witnessed transformative shifts in the birth control arena, catalyzed by patient demand for non-daily regimens and enhanced tolerability profiles. The transition from oral-only options toward long-acting reversible contraceptives has accelerated, with implants and intrauterine devices gaining prominence as women and healthcare providers seek solutions that minimize adherence challenges. Technological advancements in formulation science have also led to the rise of transdermal patches and vaginal rings capable of delivering hormones with greater precision and fewer systemic side effects.

Furthermore, the digital health revolution has empowered users with mobile-enabled monitoring tools and telemedicine platforms, facilitating remote consultations and more responsive care pathways. These converging forces are reshaping competitive dynamics, propelling established players to diversify portfolios and new entrants to leverage agile development processes.

Navigating the New Tariff Terrain for Hormonal Contraceptives

In 2025, the implementation of updated United States tariffs on imported active pharmaceutical ingredients and finished dosage forms has introduced fresh complexities into supply chain management. Manufacturers reliant on cross-border sourcing have confronted increased cost pressures, compelling a reevaluation of procurement strategies and supplier relationships. As raw material expenses rise, companies are exploring onshore production and dual-sourcing models to mitigate potential disruptions and preserve margin integrity.

Healthcare providers and pharmacy networks have felt the ripple effects as well, adjusting inventory protocols and reallocating budgetary resources to absorb higher acquisition costs. Payers are scrutinizing formularies more closely, seeking justification for premium-priced products and embracing value-based contracting to align with evolving reimbursement frameworks. These developments underscore the necessity for agility in pricing, distribution, and stakeholder engagement.

Uncovering Segmentation Dynamics Driving Market Uptake

The market’s complexity is magnified by diverse product formats and usage scenarios. From double-rod and single-rod implants to depot medroxyprogesterone acetate and norethisterone enanthate injectables, each modality presents unique adoption challenges and growth trajectories. Oral contraceptives continue to split between combined estrogen-progestin pills and progestin-only options, while intrauterine devices maintain a steady share due to their long-term protection and minimal maintenance requirements. Transdermal patches offer weekly hormone delivery without gastrointestinal impact, and vaginal rings-whether monthly or extended-use-deliver steady hormone levels with discreet administration.

Hormonal composition further segments the market into combined formulations prioritizing dual-hormone efficacy and progestin-only products favored by individuals with contraindications to estrogen. Distribution pathways span hospital, online, and brick-and-mortar pharmacies, each channel catering to distinct patient demographics. End-user dynamics range from private and public clinics to home healthcare services and hospitals, reflecting evolving models of care delivery and patient preference.

Regional Trends Shaping Global Contraceptive Access

Regional market behaviors underscore how economic maturity, healthcare infrastructure, and sociocultural factors interact. In the Americas, strong payer networks and high patient awareness have fostered broad acceptance of long-acting reversible contraceptives, with partnerships between public health agencies and private institutions boosting outreach initiatives. Europe, the Middle East & Africa showcases a mosaic of regulatory frameworks, where countries with advanced approval pathways expedite access to next-generation delivery systems while emerging markets emphasize cost-effective solutions to expand coverage.

Asia-Pacific stands out for its rapid adoption of digital health platforms and telemedicine, linking rural populations to urban medical centers and facilitating prescription fulfillment through e-commerce channels. Collaborative ventures between local manufacturers and multinational firms are optimizing production capacity and tailoring offerings to regional preferences, further stimulating uptake.

Key Market Players Steering Industry Progress

A handful of industry leaders are defining the competitive landscape through strategic investments and robust pipelines. Global pharmaceutical giants have enhanced their positions by acquiring specialized biotech firms focused on novel hormone formulations and delivery mechanisms. Simultaneously, mid-sized innovators are carving niches by advancing non-hormonal and hormone-sparing technologies, addressing unmet needs among patients seeking alternative contraception.

Collaborations between device manufacturers and pharmaceutical companies have yielded integrated product solutions that marry hardware with proprietary hormone formulations. These alliances, bolstered by licensing agreements and co-development partnerships, are accelerating time-to-market for next-generation implants, injectables, and user-controlled devices. Stakeholders who cultivate collaborative networks and uphold quality and compliance standards are poised to capture significant market share.

Strategic Imperatives for Contraceptive Industry Leadership

Industry leaders should prioritize flexible manufacturing footprints to adapt swiftly to tariff fluctuations and supply chain constraints. Investing in modular production lines that can switch between hormone types and delivery formats will enhance resilience. Equally important is the expansion of digital engagement platforms, which enable personalized patient support programs, real-time adherence tracking, and telehealth consultations that drive continued usage and brand loyalty.

Strategic partnerships with regional distributors and healthcare providers can streamline market entry in diverse regulatory environments. Executing targeted educational campaigns for both clinicians and end users will reinforce product value propositions and dispel misconceptions. Finally, embracing value-based contracting and outcome-driven agreements with payers will align commercial models with evolving reimbursement trends and secure long-term growth.

Rigorous Methodology Underpinning Our Market Insights

This analysis is underpinned by a rigorous research framework combining primary interviews with industry veterans, regulatory specialists, and healthcare practitioners, with secondary research drawing from proprietary databases, peer-reviewed journals, and government publications. Data triangulation techniques ensured consistency across diverse information sources, while sensitivity analyses probed the impact of tariff scenarios and segmentation shifts on market dynamics.

Quality safeguards included expert reviews and validation workshops to reconcile divergent viewpoints and refine key assumptions. The methodological approach prioritized transparency and reproducibility, enabling clients to trace insight derivation from raw data through to strategic recommendations.

Synthesis of Insights and Forward-Looking Perspectives

The convergence of evolving delivery technologies, shifting payer landscapes, and heightened regulatory scrutiny presents both challenges and opportunities for stakeholders in the hormonal contraceptives sector. By synthesizing macroeconomic drivers, tariff impacts, and detailed segmentation analyses, this report equips decision-makers with a holistic understanding of the forces shaping market performance.

Looking ahead, agility in manufacturing, digital engagement, and collaborative innovation will be the hallmarks of successful organizations. Those who integrate market intelligence with strategic planning processes will be best positioned to capitalize on emerging trends, minimize risk exposure, and sustain competitive advantage in a dynamic global environment.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Contraceptive Type
    • Implants
      • Double-Rod Implants
      • Single-Rod Implants
    • Injectable Contraceptives
      • Depot Medroxyprogesterone Acetate
      • Norethisterone Enanthate
    • Intrauterine Devices
    • Oral Contraceptives
      • Combined Oral Contraceptives
      • Progestin-Only Pills
    • Transdermal Patches
    • Vaginal Rings
      • Extended-Use Rings
      • Monthly Rings
  • Hormonal Composition
    • Combined Hormonal Contraceptives
    • Progestin-Only Contraceptives
  • Sales Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • End User
    • Clinics
      • Private Clinics
      • Public Clinics
    • Home Healthcare
    • Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Bayer AG
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • Allergan plc
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Gedeon Richter plc
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hormonal Contraceptives Market, by Contraceptive Type
8.1. Introduction
8.2. Implants
8.2.1. Double-Rod Implants
8.2.2. Single-Rod Implants
8.3. Injectable Contraceptives
8.3.1. Depot Medroxyprogesterone Acetate
8.3.2. Norethisterone Enanthate
8.4. Intrauterine Devices
8.5. Oral Contraceptives
8.5.1. Combined Oral Contraceptives
8.5.2. Progestin-Only Pills
8.6. Transdermal Patches
8.7. Vaginal Rings
8.7.1. Extended-Use Rings
8.7.2. Monthly Rings
9. Hormonal Contraceptives Market, by Hormonal Composition
9.1. Introduction
9.2. Combined Hormonal Contraceptives
9.3. Progestin-Only Contraceptives
10. Hormonal Contraceptives Market, by Sales Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Hormonal Contraceptives Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. Private Clinics
11.2.2. Public Clinics
11.3. Home Healthcare
11.4. Hospitals
12. Americas Hormonal Contraceptives Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Hormonal Contraceptives Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Hormonal Contraceptives Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bayer AG
15.3.2. Merck & Co., Inc.
15.3.3. Pfizer Inc.
15.3.4. Johnson & Johnson
15.3.5. Allergan plc
15.3.6. Teva Pharmaceutical Industries Ltd.
15.3.7. Viatris Inc.
15.3.8. Gedeon Richter plc
15.3.9. Sun Pharmaceutical Industries Ltd.
15.3.10. Cipla Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. HORMONAL CONTRACEPTIVES MARKET MULTI-CURRENCY
FIGURE 2. HORMONAL CONTRACEPTIVES MARKET MULTI-LANGUAGE
FIGURE 3. HORMONAL CONTRACEPTIVES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HORMONAL CONTRACEPTIVES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HORMONAL CONTRACEPTIVES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HORMONAL CONTRACEPTIVES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY DOUBLE-ROD IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY SINGLE-ROD IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY DEPOT MEDROXYPROGESTERONE ACETATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY NORETHISTERONE ENANTHATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INTRAUTERINE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PROGESTIN-ONLY PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY EXTENDED-USE RINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY MONTHLY RINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COMBINED HORMONAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PROGESTIN-ONLY CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PUBLIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 61. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 62. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 63. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 64. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 65. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 69. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 71. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 72. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 74. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 114. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 115. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 116. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 117. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 118. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 119. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 120. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 123. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 125. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 126. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 127. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 128. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 129. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 141. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 142. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 143. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 144. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 145. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 146. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 147. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 150. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 151. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 152. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 153. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 154. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 155. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 156. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 178. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 186. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 187. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 188. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 189. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 190. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 191. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 192. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 204. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 205. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 206. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 207. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 208. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 209. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 210. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 213. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 214. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 215. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 216. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 217. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 218. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 219. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 231. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 240. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 241. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 242. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 243. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 244. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 245. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 246. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 249. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 250. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 251. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 252. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 253. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 254. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 255. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 267. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 268. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 269. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 270. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 271. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 272. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 273. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 276. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 277. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 278. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 279. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 280. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 281. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 282. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 285. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 286. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 287. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 294. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 304. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 305. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 306. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 307. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 308. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 309. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 310. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 313. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 314. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 315. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 316. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 317. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RINGS, 2018-2030 (USD MILLION)
TABLE 318. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 319. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 320. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 322. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY CONTRACEPTIVE TYPE, 2018-2030 (USD MILLION)
TABLE 323. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 324. JAPAN HORMONAL CONTRACEPTIVES MARK

Companies Mentioned

The companies profiled in this Hormonal Contraceptives market report include:
  • Bayer AG
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • Allergan plc
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Gedeon Richter plc
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 19.64 Billion
Forecasted Market Value ( USD ) by 2030 $ 27.21 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Hormonal Contraceptive Market Size, Share & Trends Analysis Report By Method (Pill, IUD), By Hormone (Combination Hormonal Contraceptives, Progestin-only), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030 - Product Image

Hormonal Contraceptive Market Size, Share & Trends Analysis Report By Method (Pill, IUD), By Hormone (Combination Hormonal Contraceptives, Progestin-only), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Contraceptive Market - Global Forecast to 2030 - Product Image

Contraceptive Market - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Contraceptive Pills Market by Formulation, Packaging, Dosage Cycle, Pricing Tier, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Contraceptive Pills Market by Formulation, Packaging, Dosage Cycle, Pricing Tier, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Hormonal Contraceptive Market Report by Product (Oral Contraceptive Pills, Intrauterine Device, Injectable Birth Control, Vaginal Rings, and Others), Hormone, Age Group, End User, and Region 2024-2032 - Product Image

Hormonal Contraceptive Market Report by Product (Oral Contraceptive Pills, Intrauterine Device, Injectable Birth Control, Vaginal Rings, and Others), Hormone, Age Group, End User, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Hormonal Contraceptives Market Report 2025 - Product Image

Hormonal Contraceptives Market Report 2025

  • Report
  • 175 Pages
  • Global
From

About the Hormonal Contraceptives Market

Hormonal contraceptives are a type of personal care product used to prevent pregnancy. They are typically taken orally, injected, or implanted in the body. Hormonal contraceptives work by releasing hormones that prevent ovulation, making it difficult for sperm to reach an egg. They can also thicken the cervical mucus, making it harder for sperm to enter the uterus. Hormonal contraceptives are highly effective when used correctly and can be used for long-term contraception. Hormonal contraceptives are available in a variety of forms, including pills, patches, injections, and implants. They are available over-the-counter or by prescription, depending on the type of product. Side effects of hormonal contraceptives can include nausea, headaches, and changes in mood. Some companies in the hormonal contraceptives market include Bayer, Merck, Pfizer, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.